Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 22 Projects
Project # Contact PI Funding Organization Fiscal Year
Proteasome activator as drug candidates in Alzheimer's disease
20110802-Huang-2012 Huang, Li Alzheimer's Drug Discovery Foundation 2012
Validation of a Novel Target Mechanism to Counter Progresion of Alzheimer's Disease
2011383 20121101-Wennogle-2012 Wennogle, Lawrence Alzheimer's Drug Discovery Foundation 2012
Alzheimer's Talks: 'What's in the new National Alzheimer's Plan to stop Alzheimer's by 2025?'
2011436 20120701-Vradenburg-2012 Vradenburg, George Alzheimer's Drug Discovery Foundation 2012
Radiopharmaceutical Development for Imaging Metabotropic Glutamate Subtype 5 Receptors (mGluR5) in AD patients with PET
2011456 20121103-Vasdev-2012 VASDEV, NEIL Alzheimer's Drug Discovery Foundation 2012
New Frontiers in Neurodegenerative Disease Research
2011542 20121002-WOODLAND-2012 WOODLAND, DAVID L. Alzheimer's Drug Discovery Foundation 2012
Development of Antisense therapy and Therapeutic biomarker for C9orf72 FTD/ALS mutation patients
2011554 20121204-Rothstein-2012 ROTHSTEIN, JEFFREY D Alzheimer's Drug Discovery Foundation 2012
Testing of GLX1112 in an Alzheimer's mouse model
2011557 20121208-Reeder-2012 Reeder, Thadd Alzheimer's Drug Discovery Foundation 2012
Development of small molecule enhancers of autophagy for the clearance of protein aggregates and treatment of FTD
2011591 20121205-YU-2012 Yu, Wai Haung Alzheimer's Drug Discovery Foundation 2012
A Randomized Controlled Study to Evaluate the Effect of Bexarotene, an RXR Agonist, on beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
20120504-LANDRETH-2012 LANDRETH, GARY E. Alzheimer's Drug Discovery Foundation 2012
Preclinical development of 'painless' human Nerve Growth Factor
20120601-Cattaneo-2012 Cattaneo, Antonino Alzheimer's Drug Discovery Foundation 2012